Product Program year 2025 Source: CMS Open Payments

Amplatzer

Device Structural Heart

PDI 00811806011141

Open in the dashboard

General payments

$233,426

2,128 payments

Research payments

$32,226

25 payments

Through program year 2025, $233,426 in general payments and $32,226 in research payments were reported against Amplatzer (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $17,981 122
2024 General $4,305 50
2024 Research $1,125 1
2023 General $55,756 300
2023 Research $3,950 4
2022 General $155,384 1,656
2022 Research $27,151 20

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $233,426 2,128 payments
Top recipients General payments · program year 2025
  1. Anthony Ea Cardiovascular Disease · Mountain View, CA $8,138 45% · 19 payments
  2. Thomas Fagan Pediatric Cardiology · Madera, CA $4,809 27% · 7 payments
  3. Jenny Zablah Alabi Interventional Cardiology · Aurora, CO $89 <1% · 8 payments
  4. Gareth Morgan Interventional Cardiology · Aurora, CO $89 <1% · 8 payments
  5. Sara Negrotto Interventional Cardiology · Knoxville, TN $85 <1% · 1 payment

The top 5 of 74 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Cardiovascular Disease Internal Medicine $8,309 47% · 4 practitioners
  2. Pediatric Cardiology Pediatrics $7,269 41% · 35 practitioners
  3. Interventional Cardiology Internal Medicine $982 6% · 14 practitioners
  4. Pediatrics $453 3% · 6 practitioners
  5. Family Medicine $76 <1% · 1 practitioner

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $13,626 76% · 11 recipients
  2. Florida $469 3% · 7 recipients
  3. Texas $454 3% · 6 recipients
  4. Pennsylvania $399 2% · 6 recipients
  5. Puerto Rico $382 2% · 5 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,128 general · 25 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record